Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000102909-25-000236·Niagen Bioscience, Inc.
Schedule 13G ownership disclosure
Niagen Bioscience Inc
Common Stock · CUSIP: 171077407
Event date: 2025-09-30
- Filing-level shares
- 4,021,650
- Percent of class
- 5.04%
- The Vanguard Group
Shares: 4,021,650 · Class: 5.04%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000236
- Form type
- SCHEDULE 13G
- Filer
- Niagen Bioscience, Inc.
- CIK
- CIK 1386570
- Filed
- Oct 31, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership